EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Circulating tumor cells (CTCs) are the potential precursors of metastatic disease. Most assays established for the enumeration of CTCs so far-including the gold standard CellSearch-rely on the expression of the cell surface marker epithelial cell adhesion molecule (EpCAM). But, these approaches may...
Saved in:
| Main Authors: | Helen Schneck, Berthold Gierke, Frauke Uppenkamp, Bianca Behrens, Dieter Niederacher, Nikolas H Stoecklein, Markus F Templin, Michael Pawlak, Tanja Fehm, Hans Neubauer, Disseminated Cancer Cell Network (DCC Net) Duesseldorf |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144535&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biological roles and clinical applications of EpCAM in HCC
by: Peng Liu, et al.
Published: (2025-03-01) -
Characteristics of stem sings of EpCAM-negative and EpCAM-positive tumor cells in primary tumor and 2D and 3D cultures in breast cancer
by: V. V. Alifanov, et al.
Published: (2024-11-01) -
Construction, Expression, and Characterization of a Recombinant Immunotoxin Targeting EpCAM
by: Minghua Lv, et al.
Published: (2015-01-01) -
Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
by: Isis Wolf, et al.
Published: (2025-01-01) -
EpCAM-targeted near-infrared photoimmunotherapy (NIR-PIT) for the treatment of breast cancer
by: Aki Furusawa, et al.
Published: (2025-12-01)